Study for security evaluation of Mitoxantrone Hydrochloride and Sodium Chloride Injection 盐酸米托蒽醌氯化钠注射液安全性评价
Effects of irinotecan combined with mitoxantrone regimen in treatment of refractory or relapsing non-Hodgkin lymphoma 伊立替康联合米托恩醌治疗难治/复发性非霍奇金淋巴瘤的疗效观察
Mitoxantrone Ethylcellulose Microspheres for Liver Arte-rial Embolization 肝动脉栓塞米托蒽醌乙基纤维素微球的制剂学研究
The Combination of Mitoxantrone and Cytarabine in treatment of 30 patients with Acute Non-lymphocytic Leukemia 米托蒽醌和阿糖胞苷方案治疗急性非淋巴细胞白血病30例
Preparation of PLA-PLL-RGD Nanoparticles Loaded with Mitoxantrone 载米托蒽醌PLA-PLL-RGD纳米粒的制备
Curative effect of Mitoxantrone plus Thalidomide and Dexamethasone on treatment of multiple myeloma 米托蒽醌联合沙利度胺、地塞米松治疗多发性骨髓瘤的疗效评价
Objective To investigate the efficacy and safety of fludarabine plus mitoxantrone combination chemotherapy for malignant lymphoma compared with CHOP regimen. 目的评价并比较氟达拉滨联合米托蒽醌与CHOP方案治疗恶性淋巴瘤的疗效及安全性。
HPLC method was established for the determination of the entrapment efficiency of the liposomes loaded with vincristine sulfate and mitoxantrone hydrochloride. 建立了HPLC法测定硫酸长春新碱和盐酸米托蒽醌复方脂质体的包封率。
Objective To study the security of Mitoxantrone Hydrochloride and Sodium Chloride Injection. 目的考察盐酸米托蒽醌氯化钠注射液制剂安全性评价。
Objective: Observation of clinical curative effect and side effect for newly diagnosed and recurrent acute leukemia ( AL) using mitoxantrone ( MTZ) and other chemotherapy agents. 目的:观察米托蒽醌(MTZ)治疗初治、复发急性白血病(AL)的临床疗效和毒副作用。
Methods Spacer was used to join insulin and mitoxantrone. 方法通过间隔基连接米托蒽醌和胰岛素;
The peak current was proportional to the concentration of mitoxantrone. 峰电流与米托蒽醌的浓度成线性关系。
Anthracycline antibiotics such as daunomycin, epirubicin, mitoxantrone and congo red systems; 蒽环类抗生素柔红霉素(DNR)、表柔比星(EPI)、米托葸醌(MXT)与刚果红(CR)相互作用的反应体系;
This study was designed to assess the utility of high-dose mitoxantrone and intermediate-dose cytarabine in the treatment of patients with relapsed or refractory acute leukemia. 本研究观察了大剂量米托蒽醌和中剂量阿糖胞苷治疗30例难治性或复发的白血病的效果。
Study on drug release from mitoxantrone polylactic acid extended-release nanoparticles in vitro 米托蒽醌聚乳酸缓释毫微粒冻干针剂的体外释药特性研究
Determination of Encapsulation Rate and Encapsulation Yield of Mitoxantrone Lipid Nanospheres 米托蒽醌类脂质纳米球包封率和包封产率的测定
Activity of mitoxantrone against experimental tumors in mice 米托蒽醌对动物实验肿瘤的抑制作用
Study on mitoxantrone albumin microspheres for liver targeting 肝靶向米托蒽醌白蛋白微球的研究
A study of acute toxicity of mitoxantrone 米托蒽醌的急性毒性研究
This paper reports the toxicities of mitoxantrone in treating 37 cases with blood malignant tumour. 本文应用含米托蒽醌的化疗方案治疗37例血液恶性肿瘤,观察其毒副作用。
Clinical study on treating acute leukemia with combinative chemotherapy based on mitoxantrone 米托蒽醌为主联合化疗治疗急性白血病的临床研究
Mitoxantrone combined with etoposide in the treatment of refractory leukemia 米托蒽醌联合足叶乙甙为主方案治疗难治性恶性血液病的临床观察
Mitoxantrone, fluorouracil and leucovorin in the treatment of 41 cases with metastatic breast cancer 米托蒽醌、氟尿嘧啶与亚叶酸钙联合治疗有转移的乳腺癌41例
To evaluate the efficacy and safety of mitoxantrone in newly diagnosed childhood acute non-lymphocytic leukemia. 目的评价米托蒽醌为主的联合化疗方案在儿童初治急性非淋巴细胞性白血病治疗中的疗效与安全性。
Objective: To evaluate the effect and side effect of mitoxantrone combination chemotherapy for advanced breast cancer. 目的:观察以米托蒽醌为主的联合化疗治疗晚期乳腺癌的近期疗效与毒性反应。
Objective: To compare the encapsulation rate and encapsulation yield of mitoxantrone lipid nanospheres by dialysis and gel chromatography, thus to clarify the accurate meaning of encapsulation rate and encapsulation yield. 目的:比较透析法和凝胶柱色谱法测定米托蒽醌类脂质纳米球的包封率和包封产率的结果,阐明包封率和包封产率的准确含义。
Some anthraquinone compounds including doxorubicin, daunorubicin, doxorubicin and mitoxantrone are widely used as antitumor drugs clinically. However, these drugs may lead to bone marrow suppression, cardiac toxicity and other side effects as the dose increases to a relatively high level. 其中,多柔比星、柔红霉素、表柔比星和米托蒽醌等蒽醌类化合物都是临床上常用抗肿瘤药,但此类药物随着剂量的增加,伴有骨髓抑制、心脏毒性等副作用。